Introduction
Mental health and autoimmune disorders pose major challenges due to their complexity, variability in onset and progression, and the interplay of genetic, environmental, and neurobiological factors (Vassos et al., 2012; Wicks et al., 2005). Existing theories often focus on isolated mechanisms, which may fail to account for the dynamic, multi-system nature of these conditions. The Sensitivity Threshold Model (STM) offers an integrative hypothesis that frames these disorders as the result of chronic overload in sensitive biological systems, leading to threshold collapse and system failure.
Literature Integration Methods
This paper draws on peer-reviewed sources selected for their relevance to key STM domains, including sensory processing sensitivity (Aron & Aron, 1997), cognitive load, differential susceptibility (Belsky & Pluess, 2009), neurochemical and neurodevelopmental models of schizophrenia (Howes & Kapur, 2009), systems biology, allostatic load (McEwen, 2003), predictive coding (Friston, 2010), and epidemiological studies of stressors (Vassos et al., 2012; Wicks et al., 2005). The approach is narrative, not systematic, aimed at integrating concepts to support the hypothesis.
Empirical Support for STM Predictions
Preliminary empirical findings support key predictions of the Sensitivity Threshold Model. For example, a 2024 study observed that “the study including mostly medicated patients found that they had lower contrast sensitivity than controls while the two including unmedicated patients found better contrast sensitivity in patients” (Linares et al., 2024). This aligns with STM’s proposition that individuals may exhibit heightened sensory acuity prior to illness progression, with degradation occurring as cognitive and physiological load exceeds adaptive thresholds.
Additional qualitative and observational evidence supports STM’s assertion that individuals with schizophrenia often exhibit heightened sensory acuity prior to or during early illness stages, particularly under prodromal or acute conditions. A 2022 study by Moreno and colleagues reported firsthand accounts of enhanced auditory sensitivity in individuals with schizophrenia, noting that “such stimuli appear to be perceived as very salient in the surrounding environment by people with schizophrenia, mainly in prodromal or acute states” (Moreno et al., 2022). The observed stimuli included both extremely high-pitched alarms and insect sounds, as well as low-frequency, vibration-like noises such as air conditioners or fans—signals often unnoticed by neurotypical individuals. These findings support the STM prediction that cognitive and perceptual systems in sensitive individuals become overloaded not merely by social or emotional stress, but also by excessive or unfiltered sensory input, leading to threshold collapse and symptom emergence.
A 2012 study by Dakin et al. demonstrated striking reduced contextual suppression (Chubb illusion) in individuals with schizophrenia. Unlike healthy controls, who experienced the usual illusion where a central stimulus appears lower in contrast when surrounded by high-contrast context, patients with schizophrenia judged contrast more accurately, showing "immunity to contextual illusions". For example, in one experiment, 12 out of 15 schizophrenia participants correctly judged contrast in surrounds where healthy controls were systematically fooled. This finding aligns with STM’s prediction that, in early or unmedicated phases, sensitive individuals may perceive raw sensory input more faithfully—due to breakdowns in neural filtering or inhibitory feedback—before later overload leads to sensory degradation.
Together, these studies—on visual contrast sensitivity, auditory salience, and contextual filtering—begin to validate STM’s prediction that sensory over-responsiveness and filter failure are measurable aspects of early-stage schizophrenia, setting the stage for threshold collapse as illness progresses.
Core Hypothesis and Problem Statement
Despite decades of progress in neurobiology, immunology, and psychiatry, a unifying explanation for the onset and progression of disorders such as schizophrenia, autoimmune arthritis, type 1 diabetes, and even Alzheimer’s disease remains elusive. While existing models offer valuable mechanistic insights—such as dopaminergic dysregulation in psychosis or T-cell misrecognition in autoimmunity—they often fail to explain why these dysfunctions emerge in the first place, and why their presentation varies so widely across individuals.
Current paradigms tend to fall into one of three categories:
Neurochemical imbalance models, which locate dysfunction in static neurotransmitter anomalies
Genetic vulnerability models, which highlight inherited risk without clarifying why or when it becomes symptomatic
Stress-diathesis models, which offer a compelling but vague interaction between predisposition and life adversity
These models do not fully account for the observed variability in symptom onset, relapse patterns, and recovery trajectories. Nor do they explain the convergence of psychiatric, autoimmune, and metabolic disorders in sensitive individuals under chronic environmental or physiological stress. Critically, they lack a systems-theoretical account of why breakdown occurs when it does, and how it propagates across biological domains.
The Sensitivity Threshold Model (STM) addresses this gap by positing that many disorders—long treated as distinct—are best understood as manifestations of systemic overload in high-sensitivity biological architectures. In this view:
Each individual has a finite capacity for load processing, determined by both trait sensitivity and state vulnerability
This “load” can be cognitive, emotional, sensory, immunological, mechanical, or metabolic
When incoming load exceeds system capacity persistently or acutely, adaptive functions begin to fail, triggering cascading instability
In highly sensitive individuals, such failures occur at lower load thresholds and are more likely to spread across systems, generating misinterpretation of self vs non-self (autoimmunity), misprocessing of sensory input (psychosis), or failure of waste clearance (neurodegeneration). STM reframes schizophrenia not as a primary neurochemical disorder, but as a threshold collapse in the brain’s cognitive-integrative capacity under unmanageable load.
This core hypothesis—overload-induced failure in sensitive systems—extends to numerous conditions that are otherwise siloed across disciplines. Rather than a symptom-first taxonomy, STM proposes a load-threshold-first architecture for reclassifying modern illness and predicting trajectory.
The Sensitivity Threshold Model
STM proposes that biologically sensitive systems (e.g., sensory, immune, metabolic) operate within adaptive thresholds that, when chronically exceeded by internal or external load, trigger cascading failures. Core elements include:
- Differential individual thresholds shaped by genetics and development (Belsky & Pluess, 2009).
- Load accumulation from environmental, psychological, and physiological stressors.
- Progressive system dysregulation leading to failure modes manifesting as psychiatric, autoimmune, or degenerative disease.
- The role of feedback loops and predictive coding errors in perpetuating overload.
Application Domains
The Sensitivity Threshold Model (STM) provides a unified lens through which a wide array of disorders—traditionally viewed as mechanistically distinct—can be reinterpreted as manifestations of overload in system-specific, biologically sensitive domains. Below are select application areas where STM offers a reclassification based not on symptomatology alone, but on where the stress threshold is breached and how the system responds to cumulative load.
Schizophrenia and Psychosis
STM interprets schizophrenia as a failure of cognitive and perceptual processing under prolonged or acute overload. In highly sensitive individuals, the brain’s integrative systems—tasked with reality testing, coherence maintenance, and salience filtering—may collapse when the influx of sensory, emotional, or psychosocial stimuli exceeds tolerable bounds. Symptoms such as hallucinations, delusions, and disorganized thought are seen as downstream consequences of system destabilization, not as isolated biochemical malfunctions.
Type 1 Diabetes (T1D)
In this model, T1D emerges from metabolic overload in genetically or epigenetically sensitive pancreatic beta cells. These insulin-producing cells, under chronic glycemic volatility or inflammatory stress, emit distress signals interpreted by the immune system as pathology. STM suggests the immune attack may originate not from immune error alone, but from perceived failure of an overloaded metabolic subsystem—exceeding its threshold for stable function.
Autoimmune Arthritis (e.g., Rheumatoid Arthritis)
Here, the overloaded domain is mechanical-immune. Joint tissues subjected to chronic mechanical stress, poor repair signaling, or biochemical sensitization may begin to signal cellular distress. In susceptible individuals, this triggers immune misrecognition and attack. STM reframes autoimmune arthritis as a physical-load-triggered threshold collapse, not just a misfire of immune tolerance.
Alzheimer’s Disease and Neurodegeneration
Age is modeled in STM as an entropy amplifier: it lowers cellular resilience and diminishes the brain’s ability to clear debris and maintain homeostasis. When neurotoxic load (e.g., beta-amyloid, oxidative stress) crosses a threshold, feedback loops of cell death, inflammation, and cognitive breakdown initiate. Sedentarism, poor stimulation, and inflammation may accelerate this threshold breach.
Depression, Chronic Fatigue Syndrome (CFS), Long COVID, and Overload Syndromes
These disorders may be understood as multisystem threshold failures, where chronic stress, inflammation, immune reactivity, and sensory overload exceed the body’s regulatory capacity. STM predicts that in sensitive individuals, even low-grade stressors—if persistent—can tip the system into a fatigue-driven collapse state, consistent with post-viral syndromes or treatment-resistant depression.
By reclassifying these conditions through the lens of domain-specific sensitivity and systemic load exceedance, STM offers a unifying explanatory framework with clear implications for early detection, lifestyle intervention, and systems-level resilience strategies. Importantly, this approach complements—not contradicts—molecular and genetic findings; it contextualizes them within dynamic system behavior over time.
Theoretical Integration
The Sensitivity Threshold Model (STM) is not a rejection of existing theories but a synthesis and extension of them, reframed through the lens of systems overload and threshold failure. It draws on insights from neuroscience, psychiatry, immunology, and systems theory to contextualize known pathologies as dynamic consequences of load exceeding adaptive capacity. Below is a brief mapping of STM onto key existing frameworks.
STM builds directly on the diathesis-stress principle by specifying the nature of both vulnerability and stress. Rather than leaving these concepts broad or psychosocial alone, STM defines sensitivity as system-specific threshold fragility, and stress as cumulative load—sensory, immune, mechanical, metabolic—over time. It provides a concrete systems architecture for when and how breakdown occurs, transforming a descriptive model into a mechanistic one.
STM aligns closely with Karl Friston’s theory of the brain as a prediction engine that resists surprise (free energy). In STM, system collapse is the point at which prediction error exceeds compensatory capacity across domains. The brain, immune system, or metabolic machinery becomes unable to reduce uncertainty or adapt to influx, triggering maladaptive feedback loops. Where Friston focuses on entropy and inference, STM extends this concept to multi-system load accumulation and inter-system collapse thresholds.
Drawing from Belsky and Pluess, STM incorporates the idea that certain individuals are biologically more responsive to both environmental harm and support. STM applies this principle broadly—not just to emotional outcomes, but to immune reactivity, cognitive processing, and metabolic regulation. It predicts that sensitive individuals will manifest pathology when load exceeds thresholds but may also exhibit supernormal adaptation when supported and buffered—a vital insight for early intervention and resilience building.
STM echoes concepts from systems biology and allostasis by focusing on the cumulative toll of adaptation. It suggests that chronic compensation (e.g., heightened dopamine response, prolonged immune activation, hyperinsulinemia) ultimately destabilizes the system. STM differs by framing this not merely as wear-and-tear, but as a signal-to-load mismatch in sensitive architectures, offering a more actionable framework for identifying tipping points.
In integrating these models, STM functions as a conceptual bridge: it retains neurochemical and genetic insights but situates them within a dynamic systems context (Perrow, 1999), where overload, feedback, and sensitivity thresholds determine disease emergence and progression. This perspective lays the groundwork for multi-level diagnostics and targeted resilience engineering.
Applications Across Disorders
STM applies to schizophrenia as a model of cognitive overload-induced psychosis, to autoimmune diseases as immune system threshold failures, and to degenerative conditions as metabolic overload collapse. The model offers a theoretical lens for understanding seemingly disparate disorders linked by shared vulnerability to load-induced system failure (Catts et al., 2022; Bakulski et al., 2020; Branco et al., 2021).
Theoretical Integration
STM integrates concepts from systems neuroscience (Friston, 2010), allostatic load theory (McEwen, 2003), differential susceptibility frameworks (Belsky & Pluess, 2009), and systems failure models (Perrow, 1999). It repositions known risk factors and neurobiological findings as contributors to threshold dynamics rather than isolated defects. STM also draws from information theory, interpreting overload not merely as physiological stress but as a collapse in the signal-to-noise ratio — where internal or external noise exceeds the system’s capacity to filter and interpret salient signals. This echoes foundational work in communication systems, as formalized by Shannon (1948), and may explain why cognitive and emotional dysregulation occur under sustained stress in sensitive individuals.
Proposed Testing Framework
Empirical validation of the Sensitivity Threshold Model (STM) can proceed through several complementary approaches. First, experimental studies may assess the impact of controlled cognitive or sensory load on individuals stratified by sensitivity levels (e.g., Highly Sensitive Persons or those with known SPS traits), tracking physiological, behavioral, and neurobiological biomarkers to detect threshold effects. Second, longitudinal cohort studies could examine the interaction between baseline sensitivity markers (e.g., sensory gating, inflammatory profiles, neurocognitive reactivity), cumulative stress or environmental load, and the timing of disease onset across psychiatric and autoimmune populations. Third, computational modeling—using AI-based simulations informed by systems biology and patient datasets—can explore how small variations in sensitivity or load contribute to nonlinear threshold collapses and disease trajectories. These simulation tools may help refine STM predictions and guide future empirical studies.
Implications and Future Directions
The Sensitivity Threshold Model (STM) reframes illness as a dynamic systems collapse triggered when biologically sensitive architectures are exposed to sustained overload. This perspective shifts the focus from static dysfunction to the interplay between sensitivity, load, and adaptive capacity, offering wide-reaching implications for psychiatric, autoimmune, and degenerative conditions.
Clinically, STM encourages moving beyond symptom-based diagnosis toward predictive models grounded in resilience profiles, load exposure, and sensitivity markers. Early interventions may include reducing sensory, emotional, or inflammatory load, building cognitive and physical resilience, and using physiological or computational tools to detect threshold proximity. This model may be especially valuable for identifying high-risk individuals who appear clinically stable but are nearing a tipping point—potentially enabling preemptive strategies to prevent or reverse full-blown illness.
STM also presents rich opportunities for interdisciplinary research and computational modeling. It encourages efforts to map system-specific load-response thresholds, identify genetic and epigenetic sensitivity factors, and develop dynamic biomarkers that track overload states. To support these aims, a custom GPT-based simulator has been developed to demonstrate STM dynamics and assist in hypothesis generation and clinician education.
At its core, STM proposes that conditions such as schizophrenia, type 1 diabetes, autoimmune arthritis, depression, and Alzheimer’s disease may share a common systems-level etiology—where chronic stress exceeds adaptive limits in sensitive individuals. This unified view of illness has significant consequences not only for research and treatment, but for rethinking how health systems anticipate and manage breakdown before it becomes pathology. Researchers, clinicians, and theorists are invited to collaborate or explore the STM framework and tools further.
Disclosures, Limitations, and Access
Disclosures
The author declares no financial conflicts of interest. The STM framework and accompanying simulation tools are presented for scholarly exploration.
Limitations
This paper presents a theoretical framework without empirical validation data or clinical trials. Future studies are needed to operationalize sensitivity markers, quantify load dynamics, and validate predictions across domains.
Supplementary Materials
The following supporting information can be downloaded at the website of this paper posted on Preprints.org.
References
-
Aron, E. N., & Aron, A. (1997). Sensory-processing sensitivity and its relation to introversion and emotionality. Journal of Personality and Social Psychology, 73(2), 345–368. https://doi.org/10.1037/0022-3514.73.2.345.
-
Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to environmental influences. Psychological Bulletin, 135(6), 885–908. https://doi.org/10.1037/a0017376.
-
Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III — the final common pathway. Schizophrenia Bulletin, 35(3), 549–562. https://doi.org/10.1093/schbul/sbp006.
-
Friston, K. (2010). The free-energy principle: a unified brain theory? Nature Reviews Neuroscience, 11(2), 127–138. https://doi.org/10.1038/nrn2787.
-
Vassos, E., Pedersen, C. B., Murray, R. M., Collier, D. A., & Lewis, C. M. (2012). Meta-analysis of the association of urbanicity with schizophrenia. Schizophrenia Bulletin, 38(6), 1118–1123. https://doi.org/10.1093/schbul/sbs096.
-
Wicks, S., Hjern, A., Gunnell, D., Lewis, G., & Dalman, C. (2005). Social adversity in childhood and the risk of developing psychosis: A Swedish national cohort study. American Journal of Psychiatry, 162(12), 2349–2356. https://doi.org/10.1176/appi.ajp.162.12.2349.
-
Catts, V. S., Catts, S. V., & O’Toole, B. I. (2022). Environmental neurotoxins and schizophrenia: A review of recent findings. Environmental Health Perspectives, 130(1), 015001. https://doi.org/10.1289/EHP8151.
-
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., … & Bentall, R. P. (2012). Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophrenia Bulletin, 38(4), 661–671. https://doi.org/10.1093/schbul/sbs050.
-
Bakulski, K. M., Dou, J. F., Wu, Y., Shea, C., & Zhu, X. (2020). Lead exposure and the brain: A systematic review of neuroimaging studies in children and adults. Neurotoxicology, 81, 79–97. https://doi.org/10.1016/j.neuro.2020.08.005.
-
Branco, V., de Oliveira, D. F., Mazzari, A., Mazzari, E., & Lazzarotto, A. (2021). Mercury neurotoxicity mechanisms in humans and experimental models: Systematic review and future directions. Ecotoxicology and Environmental Safety, 213, 112017. https://doi.org/10.1016/j.ecoenv.2021.112017.
-
McEwen, B. S. (2003). Mood disorders and allostatic load. Biological Psychiatry, 54(3), 200–207. https://doi.org/10.1016/S0006-3223(03)00177-X.
-
Perrow, C. (1999). Normal accidents: Living with high-risk technologies (Updated ed.). Princeton University Press.
-
Shannon, C. E. (1948). A mathematical theory of communication. Bell System Technical Journal, 27(3), 379–423. https://doi.org/10.1002/j.1538-7305.1948.tb01338.x.
-
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011). Autoimmune diseases and severe infections as risk factors for schizophrenia: A 30-year population-based register study. American Journal of Psychiatry, 168(12), 1303–1310. https://doi.org/10.1176/appi.ajp.2011.11020316.
-
Daniel Linares, Aster Joostens, Cristina de la Malla, A Systematic Review and Meta-Analysis on Contrast Sensitivity in Schizophrenia, Schizophrenia Bulletin, 2024;, sbae194, https://doi.org/10.1093/schbul/sbae194.
-
Moreno, J. A., Maldonado, L. D. S., Salazar, E. G. F., Ramos, R., González, R. A. R., & De la Fuente-Sandoval, C. (2022). Schizophrenia and hearing: A first-person account-based hypothesis on enhanced auditory sensitivity. Frontiers in Psychiatry, 13, 927686. https://doi.org/10.3389/fpsyt.2022.927686PMC ID: PMC9276868.
-
Dakin, S., Carlin, P., & Hemsley, D. (2005). Weak suppression of visual context in chronic schizophrenia. Current Biology, 15(20), R822–R824. https://doi.org/10.1016/j.cub.2005.10.015.
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).